Memory Unit

Terrassa, Spain

Memory Unit

Terrassa, Spain
SEARCH FILTERS
Time filter
Source Type

Cerulla N.,Memory Unit | Cerulla N.,Cognition and Behaviour Research Group | Cerulla N.,Autonomous University of Barcelona | Arcusa A.,Consorci Sanitari de Terrassa CST | And 5 more authors.
Breast Cancer Research and Treatment | Year: 2017

Purpose: The aim of this study is to elucidate the role of taxanes on cognition when they are administered as a part of the treatment with a fluorouracil, epirubicin and cyclophosphamide (FEC) regimen for breast cancer (BC). Methods: Two groups of women (n = 51) with a novel diagnostic of BC that were treated with a combination of FEC alone (6 cycles of FEC) or with taxanes (4 cycles of FEC plus 8 cycles of taxanes) were compared at three moments: before chemotherapy, after its completion (short-term evaluation) and at a mean of 74.5 weeks from baseline as a long-term evaluation. Results: Both groups showed worsening in tests of attention and executive functions on the short-term assessment, with the group treated with taxanes showing more number of affected cognitive measures at this time point, including verbal learning and speed measures. At the long-term evaluation, cognitive dysfunction was still found in attention and executive functions in both groups. Conclusion: Our results suggest that chemotherapy for BC with a FEC regimen can have a negative effect on cognition. Acute deficits seem to be larger when taxanes are added, but treatment seems to affect cognition also at long term. © 2017 Springer Science+Business Media New York

Loading Memory Unit collaborators
Loading Memory Unit collaborators